Review of the textbook “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events”
https://doi.org/10.37489/2782-3784-myrwd-51
EDN: TJLIQC
Abstract
The European SocIn March 2024, the manual “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events” was published under general ed. Kolbin A. S. This textbook discusses biotechnological drugs from the perspective of clinical pharmacology. Basic definitions and classifications are given. Pharmacodynamics, pharmacokinetics and adverse events are reviewed. Examples of interactions between biotechnological drugs and small molecules are presented. A separate chapter examines the interchangeability of biological products — from basic terms and definitions of the concept of biosimilarity to regulatory aspects. The Appendix provides examples of clinical applications of therapeutic proteins. The manual is intended for students, residents, graduate students, clinical pharmacologists and physicians of other specialties.
About the Author
V. I. PetrovRussian Federation
Vladimir I. Petrov — DM, Professor, Academician of the Russian Academy of Sciences, President of the Volgograd State Medical University; head Department of Clinical Pharmacology and Intensive Care; chief freelance specialist — clinical pharmacologist of the Russian Ministry of Health; President of the Association of Clinical Pharmacologists
Volgograd
Review
For citations:
Petrov V.I. Review of the textbook “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events”. Real-World Data & Evidence. 2024;4(1):66-68. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-51. EDN: TJLIQC